The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act represents ‘the best way’ to deal with the hemp-CBD issue for dietary supplements, says CRN’s Steve Mister, and once that’s clarified then the FDA and industry can address...
Fish oils supplier KD Pharma has moved more aggressively into the cannabinoid space with the acquisition of the manufacturing assets of a Swiss CBD and phyotextract specialist firm, the company announced today.
A recent paper claims FDA is in the dark as to how many new ingredients have come onto the market via the GRAS process. Only limited progress has been made in the decade since a Congressional report first raised the issue and directed the Agency to make...
The manufacturer of a multivitamin has withdrawn a number of claims relating to the purported benefits its product has for hyperactive children as part of a National Advertising Division case.
The Irish Joint Committee on Health has launched a report on Vitamin D deficiency concluding that the Government must promote supplementation across the population by increasing public knowledge and reducing costs.
The trade association for the infant formula industry has flagged a number of ads by Kendamil that they believe breach codes restricting the marketing of these foods.
The United States is the first country to administer 150 million COVID-19 vaccine doses, setting the nation up to meet President Biden's goal of administering 200 million shots in his first 100 days in office. One company is seeking to capitalize...
A warning letter sent to a Connecticut wholesaler about the sale of pure powdered caffeine points to the difficulty of keeping problematic products off the market in an environment in which hundreds of thousands of tons of cargo arrives in domestic ports...
Imagine taking the time and effort to cultivate hemp across hundreds of acres, only to find out that your harvest is contaminated. The damage can cause an odor, spoilage or significant illness to the end user if left unchecked.
Efforts to move the needle on hemp-CBD at the Federal level are slow, and upcoming exits of key personnel at FDA are unlikely to affect progress much, says NPA’s Dr Daniel Fabricant. “In some ways I think FDA likes the status quo,” he tells NutraIngredients-USA.
The state of Colorado aims to remain a leader in the hemp industry, Gov. Jared Polis said at an industry event last week. He announced the release of a detailed state plan for the industry at the meeting, which includes scientific support, data sharing,...
The European Commission (EC) is to ban botanical species containing hydroxyanthracene derivatives (HADs) that includes aloe extracts in a decision set to have implications for the nutrition and nutricosmetic industry.